The forecast for non-steroid anti-inflammatory and antirheumatic medicine sales in Germany shows a consistent decline in the percentage of total sales from 2024 to 2028. Sales are expected to decrease from 0.7% in 2024 and 2025, to 0.6% in 2026, further dropping to 0.5% in 2027 and 2028. This trend indicates a steady decrease over the years, with a notable downturn starting in 2026. These figures reflect a cautious market outlook, suggesting shrinking market share for these medicines.
Future trends to watch for include potential innovations or breakthroughs in alternative treatments that could further impact non-steroidal anti-inflammatory drug sales. Additionally, market dynamics such as regulatory changes or shifts in consumer preference towards alternative therapies could influence the projected trajectory.
